BioSpace News Archive

Urovant Sciences, a wholly owned subsidiary of Sumitovant Biopharma Ltd., receives coveted Best in Category award for an interim 12-week analysis from the ongoing Phase 2a trial of an investigational novel gene therapy product, URO-902 (plasmid human cDNA encoding maxi-K channel).

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) (“ScreenPro” or the “Company”) is pleased to announce that the Company has appointed Mr. Andrew Ryu as the new interim Chief Executive Officer and Chairman effective September 8, 2022.

BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) (“BioMark”) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today that it’s abstract titled “Metabolomic Profiling for the Early Detection of Lung Cancer” has been accepted for presentation at the upcoming ESMO Congress 2022 taking place on September 9 – 13, 2022 in Paris, France.

Blue Water Vaccines Inc. a biopharmaceutical company developing transformational vaccines to address significant global health challenges, announced an update to its presentation at the H.C. Wainwright 24th Annual Global Investment Conference.

The European Patent Office has announced to approve Bioretec Oy’s hybrid composite material patent application EP3782657A1 and will grant and publish the patent after the Company’s confirmation.

Cancer is rapidly becoming a global concern. According to 2015 report by the American Cancer Society, 1 in 8 deaths globally is due to cancer.

The global prurigo nodularis treatment market is anticipated to gather pace in its growth due to the rarity of the disease.

Post-traumatic stress disorder (PTSD) refers to a psychological condition that affects people of any gender or age group.

The global breast cancer diagnostics market was valued at US$ 4.8 Bn in 2018 and is projected to expand at a high CAGR from 2019 to 2027.

Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.